|
Name |
(1R,2R,5S,7R,10R)-5,7-dihydroxy-14-(4-methoxyphenyl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-diene-3,16-dione
|
| Molecular Formula | C27H32O7 | |
| IUPAC Name* |
(1R,2R,5S,7R,10R)-5,7-dihydroxy-14-(4-methoxyphenyl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-diene-3,16-dione
|
|
| SMILES |
C[C@@]12CC[C@@]3([C@@]([C@H]1CC4=C(O2)C=C(OC4=O)C5=CC=C(C=C5)OC)(C(=O)C[C@@H](C3(C)C)O)C)O
|
|
| InChI |
InChI=1S/C27H32O7/c1-24(2)21(28)14-22(29)26(4)20-12-17-19(34-25(20,3)10-11-27(24,26)31)13-18(33-23(17)30)15-6-8-16(32-5)9-7-15/h6-9,13,20-21,28,31H,10-12,14H2,1-5H3/t20-,21-,25+,26-,27+/m0/s1
|
|
| InChIKey |
OXYZEYLPMGOMEK-UCHDDLIBSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | 102132270 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 468.5 | ALogp: | 2.7 |
| HBD: | 2 | HBA: | 7 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 102.0 | Aromatic Rings: | 5 |
| Heavy Atoms: | 34 | QED Weighted: | 0.679 |
| Caco-2 Permeability: | -4.778 | MDCK Permeability: | 0.00002370 |
| Pgp-inhibitor: | 0.985 | Pgp-substrate: | 0.816 |
| Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.414 |
| 30% Bioavailability (F30%): | 0.906 |
| Blood-Brain-Barrier Penetration (BBB): | 0.841 | Plasma Protein Binding (PPB): | 88.04% |
| Volume Distribution (VD): | 0.859 | Fu: | 9.55% |
| CYP1A2-inhibitor: | 0.341 | CYP1A2-substrate: | 0.858 |
| CYP2C19-inhibitor: | 0.767 | CYP2C19-substrate: | 0.593 |
| CYP2C9-inhibitor: | 0.872 | CYP2C9-substrate: | 0.687 |
| CYP2D6-inhibitor: | 0.065 | CYP2D6-substrate: | 0.876 |
| CYP3A4-inhibitor: | 0.765 | CYP3A4-substrate: | 0.473 |
| Clearance (CL): | 7.945 | Half-life (T1/2): | 0.316 |
| hERG Blockers: | 0.527 | Human Hepatotoxicity (H-HT): | 0.669 |
| Drug-inuced Liver Injury (DILI): | 0.347 | AMES Toxicity: | 0.012 |
| Rat Oral Acute Toxicity: | 0.973 | Maximum Recommended Daily Dose: | 0.936 |
| Skin Sensitization: | 0.185 | Carcinogencity: | 0.773 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
| Respiratory Toxicity: | 0.963 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002037 | ![]() |
0.752 | D06XZW | ![]() |
0.261 | ||
| ENC003232 | ![]() |
0.725 | D0N0RU | ![]() |
0.254 | ||
| ENC003130 | ![]() |
0.685 | D0P1UX | ![]() |
0.252 | ||
| ENC005020 | ![]() |
0.445 | D04UTT | ![]() |
0.248 | ||
| ENC002192 | ![]() |
0.435 | D09WKB | ![]() |
0.246 | ||
| ENC000932 | ![]() |
0.419 | D06HBQ | ![]() |
0.241 | ||
| ENC002118 | ![]() |
0.404 | D06GCK | ![]() |
0.237 | ||
| ENC002044 | ![]() |
0.400 | D03SKD | ![]() |
0.234 | ||
| ENC003423 | ![]() |
0.394 | D0J1ML | ![]() |
0.234 | ||
| ENC003422 | ![]() |
0.394 | D02DPU | ![]() |
0.232 | ||